250 West 55th Street, Suite 16B, New York, NY
United States of America

EDAP TMS articles

Displaying 1 - 1 of 1

Focal One receives FDA clearance

Focal One receives FDA clearance
EDAP TMS has announced that it has received 510(k) clearance from the FDA for its Focal One device for the ablation of prostate tissue. The Focal One high intensity focused ultrasound (HIFU) device is the first medical apparatus designed specifically for focal treatment of the prostate. Focal One fuses MR and 3D biopsy data with real-time ultrasound imaging, which allows urologists to view integrated, detailed 3D images of the prostate on a large monitor and direct high intensity ultrasound waves to ablate the targeted area.
13th June 2018

Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

HETT 2019
1st October 2019
United Kingdom EXCEL, London
New Scientist Live 2019
10th October 2019
United Kingdom ExCeL, London
GIANT Health Event 2019
15th October 2019
United Kingdom Chelsea Football Club Stadium, London